Fidelity Investments
OTLK icon

Fidelity Investments’s Outlook Therapeutics OTLK Stock Holding History

Fidelity Investments’s Portfolio OTLK Stock Details OTLK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-606
Closed -$957 – 5527
2025
Q4 		$957 Buy
606
+500
+472% +$799 ﹤0.01% 5101
2025
Q3 		$112 Sell
106
-170,396
-100% -$295K ﹤0.01% 5196
2025
Q2 		$273K Sell
170,502
-4,735
-3% -$7.55K ﹤0.01% 3198
2025
Q1 		$214K Sell
175,237
-6,284
-3% -$11K ﹤0.01% 3219
2024
Q4 		$343K Buy
181,521
+180,334
+15,192% +$742K ﹤0.01% 3056
2024
Q3 		$6.34K Buy
1,187
+286
+32% +$2.09K ﹤0.01% 4560
2024
Q2 		$6.65K Buy
901
+228
+34% +$1.83K ﹤0.01% 4466
2024
Q1 		$8.04K Sell
673
-621
-48% -$5.02K ﹤0.01% 4352
2023
Q4 		$10.2K Buy
1,294
+1,189
+1,132% +$10.1K ﹤0.01% 4235
2023
Q3 		$464 Sell
105
-345
-77% -$7.63K ﹤0.01% 4720
2023
Q2 		$15.7K Buy
450
+224
+99% +$6.11K ﹤0.01% 3972
2023
Q1 		$4.94K Sell
226
-300
-57% -$6.71K ﹤0.01% 4393
2022
Q4 		$11.4K Sell
526
-7,562
-93% -$164K ﹤0.01% 3965
2022
Q3 		$197K Buy
+8,088
New +$188K ﹤0.01% 3055
2022
Q2 		– Sell
-58
Closed -$1.67K – 5330
2022
Q1 		$2K Buy
58
+54
+1,350% +$1.69K ﹤0.01% 4691
2021
Q4 		$0 Buy
+4
New +$143 ﹤0.01% 4772

Other funds holding OTLK

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GWM
Gilpin Wealth Management Denver, Colorado $126M AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
WAM
Warberg Asset Management Winnetka, Illinois $600M AUM 23.37% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
NMC
Nine Masts Capital Central, Hong Kong $693M AUM 31.93% 1-Year Est. Return
CCM
Connective Capital Management Palo Alto, California $121M AUM 39.82% 1-Year Est. Return

Fidelity Investments's OTLK Position: Q1 2026 in Review

Fidelity Investments sold out of Outlook Therapeutics (OTLK) in Q1 2026, closing a stake of 606 shares — an estimated $957 sold.

Fidelity Investments first reported a position in OTLK in Q4 2021 and held it in 16 quarters. The position peaked at $343K in Q4 2024. 54 funds tracked by Wall St. Rank hold OTLK as of Q1 2026.

  • Fidelity Investments reported no remaining Outlook Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Fidelity Investments sold 606 Outlook Therapeutics shares in Q1 2026, an estimated $957.
  • Fidelity Investments first reported a position in Outlook Therapeutics in Q4 2021 and held it in 16 quarters.
  • Fidelity Investments's Outlook Therapeutics position peaked at $343K in Q4 2024.
  • 54 funds tracked by Wall St. Rank held Outlook Therapeutics as of Q1 2026.

Based on Fidelity Investments's 13F filing for Q1 2026, filed 15 May 2026.